GW Pharmaceuticals Plc/ US36197T1034 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | -USD | - | - |
Fundamentals
| FY 2020 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.15 USD | 650.00% |
| EPS Diluted: | -0.15 USD | 650.00% |
| Revenues per Share: | - USD | - |
| Book Value per Share: | - USD | - |
| Cash Flow per Share: | - USD | - |
| Dividend per Share: | 0.00 USD | - |
| Total | in mill. | |
| Revenues: | 527.20 USD | 69.35% |
| Net Income: | -58.10 USD | 545.56% |
| Operating Cash Flow: | -27.40 USD | - |
| Cash and Cash Equivalents: | 486.80 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | - | - |
| P/BV ratio: | - | - |
| P/CF Ratio: | - | - |
| PEG: | - | - |
| Earnings Yield: | - | -0.13% |
| Dividend Yield: | - | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | - USD | - USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | 37.34 mill. USD |
| Shares Outstanding: | 368.97 mill. | |
Profitability
| Gross Profit Margin: | 100.00% |
| EBIT Margin: | -9.83% |
| Net Profit Margin: | -11.02% |
| Return on Equity: | -7.84% |
| Return on Assets: | -6.18% |
Financial Strength
| Liquidity I / Cash Ratio: | 304.63% |
| Liquidity II / Quick Ratio: | 349.19% |
| Liquidity III / Current Ratio: | 456.51% |
| Debt / Equity Ratio: | 26.77% |
| Dynam. Debt / Equity Ratio: | -724.09% |
Efficiency
| Employees: | 1,161 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 454,091.30 USD |
| Net Income / Employee: | -50,043.07 USD |
| Total Assets / Employee: | 809,216.19 USD |
| * Fiscal Year End: | 2020-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
